GALLUZZO, Aldo
 Distribuzione geografica
Continente #
NA - Nord America 8.141
EU - Europa 4.190
AS - Asia 3.079
SA - Sud America 445
Continente sconosciuto - Info sul continente non disponibili 276
AF - Africa 138
OC - Oceania 2
Totale 16.271
Nazione #
US - Stati Uniti d'America 7.983
SG - Singapore 1.068
RU - Federazione Russa 860
CN - Cina 822
IT - Italia 794
FI - Finlandia 641
UA - Ucraina 502
DE - Germania 423
BR - Brasile 313
HK - Hong Kong 298
VN - Vietnam 269
GB - Regno Unito 182
PL - Polonia 174
FR - Francia 166
IE - Irlanda 166
BD - Bangladesh 110
JP - Giappone 105
SE - Svezia 104
IN - India 94
KR - Corea 75
CA - Canada 69
CI - Costa d'Avorio 62
TR - Turchia 43
MX - Messico 38
IQ - Iraq 37
NL - Olanda 36
BE - Belgio 34
CO - Colombia 31
EC - Ecuador 31
AR - Argentina 30
PK - Pakistan 19
ZA - Sudafrica 19
IR - Iran 18
CZ - Repubblica Ceca 16
JM - Giamaica 14
RO - Romania 14
SA - Arabia Saudita 13
CH - Svizzera 12
ID - Indonesia 12
MA - Marocco 12
AT - Austria 11
CL - Cile 11
DZ - Algeria 11
EG - Egitto 11
MY - Malesia 11
ES - Italia 10
KE - Kenya 10
TN - Tunisia 10
VE - Venezuela 10
UZ - Uzbekistan 9
AE - Emirati Arabi Uniti 8
AZ - Azerbaigian 8
HN - Honduras 7
IL - Israele 7
JO - Giordania 7
PH - Filippine 7
PY - Paraguay 7
AL - Albania 6
CR - Costa Rica 6
EU - Europa 6
LT - Lituania 6
NI - Nicaragua 6
TH - Thailandia 6
BG - Bulgaria 5
EE - Estonia 5
KZ - Kazakistan 5
UY - Uruguay 5
GD - Grenada 4
KG - Kirghizistan 4
OM - Oman 4
PE - Perù 4
BH - Bahrain 3
BY - Bielorussia 3
DK - Danimarca 3
DO - Repubblica Dominicana 3
GR - Grecia 3
GT - Guatemala 3
LB - Libano 3
NP - Nepal 3
BA - Bosnia-Erzegovina 2
BN - Brunei Darussalam 2
CY - Cipro 2
HU - Ungheria 2
MD - Moldavia 2
PA - Panama 2
PR - Porto Rico 2
PT - Portogallo 2
QA - Qatar 2
SI - Slovenia 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AM - Armenia 1
AO - Angola 1
AU - Australia 1
BB - Barbados 1
BO - Bolivia 1
BS - Bahamas 1
BZ - Belize 1
CG - Congo 1
GE - Georgia 1
GY - Guiana 1
Totale 15.991
Città #
Ashburn 949
Singapore 699
Fairfield 535
Chandler 428
San Jose 428
Houston 374
Ann Arbor 334
Woodbridge 329
Hong Kong 286
Jacksonville 284
Wilmington 234
Seattle 202
Cambridge 180
Dublin 166
Palermo 155
Zgierz 150
Moscow 145
Council Bluffs 123
Des Moines 112
Medford 112
Beijing 111
New York 111
Munich 105
Tokyo 100
Santa Clara 99
Frankfurt am Main 98
Los Angeles 97
The Dalles 97
Nanjing 96
Ho Chi Minh City 95
Boardman 83
Helsinki 83
Dallas 80
Princeton 75
Chicago 73
Dearborn 71
Lauterbourg 63
Abidjan 62
Tulsa 59
Altamura 54
Hanoi 54
Buffalo 50
Changsha 47
Shenyang 45
Jinan 44
Atlanta 41
San Diego 41
Hebei 36
Milan 35
São Paulo 35
Lawrence 34
Brussels 31
Jiaxing 27
Seongnam 27
Nanchang 26
Kumar 25
Venice 25
Da Nang 24
Ningbo 24
Phoenix 21
Tianjin 21
Hefei 20
London 20
Denver 19
Columbus 18
Ludwigshafen am Rhein 18
Boston 17
Guangzhou 17
Verona 17
Washington 17
Amsterdam 16
Falls Church 16
Hangzhou 16
Orem 16
Bologna 15
Rome 15
Toronto 15
Zhengzhou 15
Baghdad 14
Chennai 14
Durham 14
Izmir 14
Brno 13
Frankfurt 13
Guayaquil 13
Manchester 13
Montreal 13
Saint Petersburg 13
Taizhou 12
Tehran 12
Brasília 11
Kingston 11
Mexico City 11
Nuremberg 11
Philadelphia 11
Secaucus 11
Warsaw 11
Johannesburg 10
Quito 10
Redwood City 10
Totale 9.202
Nome #
Differente pattern di espressione di citochine a fenotipo Th1 e Th2 nei pazienti affetti da diabete di tipo 1 (T1DM) e con associata tireopatia autoimmune (AITD) 425
Effects on the incidence of cardiovascular events of the addition of pioglitazone versus sulfonylureas in patients with type 2 diabetes inadequately controlled with metformin (TOSCA.IT): a randomised, multicentre trial 398
L’espressione del “peroxisome proliferator-activated gamma” (PPARgamma) nelle tireopatie croniche autoimmuni 359
BRAFV600E mutation, TIMP-1 up-regulation and NF-{kappa}B activation: closing the loop on the papillary thyroid cancer trilogy. 354
Iter diagnostico "rapido" per un caso di MEN IIb in un giovane adolescente 351
Predictors of microvascular complications in type 1 diabetic patients at onset: The role of metabolic memory 345
Visceral adiposity index is associated with significant fibrosis in patients with non-alcoholic fatty liver disease 341
In vitro generation of pancreatic endocrine cells from human adult fibroblast-like limbal stem cells 334
In Vitro Phenotypic, Genomic and Proteomic Characterization of a Cytokine-Resistant Murine β-TC3 Cell Line 311
In vitro identification and characterization of CD133pos cancer stem-like cells in anaplastic thyroid carcinoma cell lines 308
Metabolic parameters and adipokine profile during GH replacement therapy in children with GH deficiency 283
BRAFV600E Mutation and p27kip1 Expression in Papillary Carcinomas of the Thyroid ≤1 cm and Their Paired Lymph Node Metastases 280
Fine-Needle Aspiration (FNAB) Molecular Analysis for the Diagnosis of Papillary Thyroid Carcinoma through BRAFv600E mutation and RET/PTC rearrangement 273
Cornea in acromegalic patients as a possible target of growth hormone action. 267
Oligomenorrhea in PCOS is characterized by a high visceral adiposity index (VAI): a likely condition of cardiometabolic risk. 266
Development of a fuzzy expert system for the control of glycemia in type 1 diabetic patients 266
OCT is not useful for detection of minimal diabetic retinopathy in type 1 diabetes. 252
The evaluation of metabolic parameters and insulin sensitivity for a more robust diagnosis of the polycystic ovary syndrome 250
Visceral Adiposity Index (VAI): A Reliable Indicator Of Visceral Fat Function Associated With Cardiometabolic Risk. 249
Janus kinase (JAK) 2 V617F mutation as the cause of primary thrombocythemia in acromegaly with severe visceromegaly and divergence between growth hormone and insulin-like growth factor-1 concentrations during the follow-up: causal or casual association? 249
Cut-off points of the visceral adiposity index (VAI) identifying a visceral adipose dysfunction associated with cardiometabolic risk in a Caucasian Sicilian population. 247
Different Th1/Th2 cytokine expression in Type 1 diabetes mellitus patients (T1DM) alone or associated with autoimmune thyroid disease (AITD) 245
Outcome of pregnancy in type 1 diabetic patients treated with insulin lispro or regular insulin: an Italian experience 235
Use of Glargine in Pregnant Women with Type 1 Diabetes Mellitus: A Case-Control Study 234
Transient chylomicronemia preceding the onset of insulin-dependent diabetes in a young girl with no humoral markers of islet autoimmunity. 222
Effect of lercanidipine compared with ramipril on albumin excretion rate in hyprtensive Type 2 diabetic patients with microalbuminuria. DIAL Study (Ddiabete, Ipertensione, Albuminuria, Lercanidipina) 220
Il c-peptide come marker principale nella storia naturale del Diabete tipo 1: ruolo della funzione b-cellulare pancreatica nelle complicanze 219
Difficoltà di identificazione della sindrome MEN2B ad esordio infantile: iter diagnostico. 219
Cellule Staminali Pancreatiche 216
Identification of Tyrosine Phosphatase 2(256-760) Construct as a New, Sensitive Marker for the Detection of Islet Autoimmunity in Type 2 Diabetic Patients: The Non Insulin Requiring Autoimmune Diabetes (NIRAD) Study 2 213
Relative Hypoleptinemia in poor controlled patients with Type 1 Diabetes 209
Decremento delle cellule T regolatorie (Treg) CD4+CD25+FOXP3+ nei linfociti periferici dei pazienti affetti da diabete di tipo 1. 209
Visceral adiposity index is associated with insulin sensitivity and adipocytokine levels in newly diagnosed acromegalic patients. 208
Distinct subsets of intrathyroidal regulatory CD4+CD25+ and CD8+CD25+ T cells in Hashimoto's thyroiditis: Potential role in the neoplastic cell growth. 207
Use of the Diabetes Risk Score for Opportunistic Screening of Undiagnosed Diabetes and Impaired Glucose Tolerance 206
No association between BRAFV660E and metalloproteinase activity in anaplastic thyroid cell lines 205
Valutazione dell'insulinoresistenza tramite un test pasto standard 204
Systolic flow peak of inferior thyroid arteries in Graves’disease: A predictive parameter for the ophalmopathy development. 200
Amplificazione real-time allele-specifica per l'individuazione della mutazione V600E del B-RAF nel carcinoma papillare su agoaspirato tiroideo. 200
High expression of peroxisome proliferator-activated receptor gamma (PPRgamma) in infiltrating lymphocytes from glands with Hashimoto's thyroiditis. 198
Rosiglitazone evaluated for cardiovascular outcomes in oral agent combination therapy for type 2 diabetes (RECORD): a multicentre, randomised, open-label trial 195
Changes in lipid profile and adipokine levels in GH deficient children during GH replacement therapy. 190
Low estradiol-to-testosterone ratio is associated with oligo-anovulatory cycles and atherogenic lipidic pattern in women with polycystic ovary syndrome. 190
Adrenal incidentaloma: a new contributing factor in metabolic syndrome 187
Rotterdam consensus, NIH and EAS: comparison among the three different diagnostic criteria for the diagnosis of PCOS. 186
L’uso del hrTSH nel follow up del microcarcinoma tiroideo in pazienti sottoposti a tiroidectomia totale 186
L’espressione di citochine TH1 e TH2 nei pazienti affetti da tireopatia autoimmune (AITD) e diabete di tipo 1 185
Identification and enrichment of thyroid stem cells in anaplastic cell lines 185
GH-suppression test in acromegaly: comparison between OGTT and chocolate test 183
Leptina e adiponectina nella valutazione del compenso glicometabolico in corso di diabete mellito di tipo 1 normopeso. 182
Sviluppo di un sistema di supporto decisionale tipo Fuzzy per il controllo della glicemia post-prandiale nel diabete mellito tipo 1 181
Alterazioni del metabolismo glucidico determinate da eccesso di ormoni contro regolatori. 178
Lower insulin sensitivity differentiates hirsute from non-hirsute Sicilian women with polycystic ovary syndrome 178
Detection of BRAFv600E mutation in papillary thyroid carcinoma using real time allele-specific amplification on fine needle aspiration biopsy specimens. 176
Antitumor effect of aminobisphosphonates on anaplastic thyroid carcinoma cell lines. 175
Congenital anomaly rate in offspring of Italian mothers with type 1 diabetes treated with insulin lyspro during pregnancy 171
Hypothyroidism induced by esophageal adenocarcinoma metastates: a case report 168
Peak systolic velocity (PSV) in inferior thyroid arteries (ITA) at Graves'disease onset is predictive of the risk for ophtalmopathy development 164
The oligomenorrhoic phenotypes of polycystic ovary syndrome are characterized by a high visceral adiposity index: a likely condition of cardiometabolic risk. 162
Th1 and Th2 cell phenotypes in AITD: role of allergy in Graves’ disease 158
Visceral adiposity index is associated with histological findings and high viral load in patients with chronic hepatitis C due to genotype 1. 157
Glycemic durability of rosiglitazone, metformin or glyburide monotherapy 154
Insulin sensitivity and visceral adiposity index (VAI) in women with functional secondary amenorrhea. 153
Complete biochemical control and oituitary adenoma disappearance in a child with gigantism: efficay of octreotide therapy 151
Adrenal morphology and function in acromegalic patients in relation to disease activity. 150
Low hrTSH-Tg levels in patients affected by papillary thyroid microcarcinoma are influenced by pre-surgery L-thyroxine therapy. 148
Insulin resistance and polycystic ovary syndrome. 148
Effect of candesartan on prevention (DIRECT-Prevent 1) and progression (DIRECT-Protect 1) of retinopathy in type 1 diabetes: randomised, placebo-controlled trials. 147
Effect of candesartan on progression and regression of retinopathy in type 2 diabetes (DIRECT-Protect 2): a randomised placebo-controlled trial. 144
Up-regulation of c-FLIPshort and Reduction of Activation-Induced Cell Death in T-cells from Patients with Type 1 Diabetes 137
Once-daily basal insulin glargine versus thrice-daily prandial insulin lispro in people with type 2 diabetes on oral hypoglycaemic agents (APOLLO): an open randomised controlled trial. 132
Increated central corneal thickness in acromegalic patients 121
null 104
Phenotipic characteristics of GAD Antibody-positive recently diagnosed patients with type 2 diabetes in North America and Europe 97
Valutazione morfologica e funzionale surrenalica nell’acromegalia 92
Influences of obesity and weight loss on thyroid hormones. A 3-3.5-year follow-up study on obese subjects with surgical bilio-pancreatic by-pass 92
null 87
Totale 16.271
Categoria #
all - tutte 46.862
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 46.862


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022721 0 0 0 39 77 34 42 39 89 132 91 178
2022/20231.149 111 194 25 122 141 183 89 75 148 10 42 9
2023/2024511 21 88 17 43 47 144 32 40 9 6 6 58
2024/20251.486 61 79 102 121 57 65 99 123 115 141 249 274
2025/20264.975 361 131 208 352 457 741 670 540 299 769 205 242
2026/20271.801 224 718 668 191 0 0 0 0 0 0 0 0
Totale 16.271